Cowen And Company, LLC Iovance Biotherapeutics, Inc. Call Options Transaction History

Cowen And Company, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $1.08 Million - $1.8 Million	-65,200 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$20.35 - $26.63 $1.33 Million - $1.74 Million	65,200 New	65,200 $72,000
Q1 2021 May 04, 2021	SELL	$28.67 - $52.59 $1 Million - $1.84 Million	-35,000 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$28.04 - $50.26 $148,612 - $266,378	-5,300 Reduced 13.15%	35,000 $120,000
Q3 2020 Nov 03, 2020	SELL	$27.75 - $36.3 $144,300 - $188,759	-5,200 Reduced 11.43%	40,300 $31,000
Q2 2020 Aug 13, 2020	SELL	$27.21 - $41.0 $1.34 Million - $2.02 Million	-49,300 Reduced 52.0%	45,500 $12,000
Q1 2020 May 11, 2020	BUY	$19.54 - $38.85 $1.49 Million - $2.96 Million	76,300 Added 412.43%	94,800 $224,000
Q4 2019 Feb 11, 2020	SELL	$17.95 - $29.41 $940,580 - $1.54 Million	-52,400 Reduced 73.91%	18,500 $65,000
Q3 2019 Nov 12, 2019	BUY	$17.99 - $26.0 $1.28 Million - $1.84 Million	70,900 New	70,900 $50,000

316

244M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $898M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.